Waldencast plc (WALDW) स्टॉक विश्लेषण

कंपनी का अवलोकन

Waldencast plc operates within the beauty and wellness industry, serving a global footprint that includes the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The corporation generates revenue primarily through two distinct business segments: Obagi Medical and Milk Makeup, which collectively offer skin care products designed to minimize signs of skin aging and address dark spots. While the specific sector and industry classifications are listed as N/A in available records, the company maintains a workforce of 367 employees to support its international operations. The available data indicates a market cap and price-to-sales ratio are N/A, suggesting the valuation framework relies heavily on asset-based metrics rather than traditional earnings multiples. This absence of standard multiple valuations implies that the company's market position is currently assessed through its tangible book value rather than speculative growth expectations.

वित्तीय स्वास्थ्य

The company reported a trailing twelve-month revenue of $272.07M, yet simultaneously recorded a net income of $-229,748,992 and an EBITDA of $-5,782,000. The substantial disparity between the $272.07M revenue and the negative net income reveals a cost structure where operating expenses and losses significantly outweigh gross profits. Despite the negative earnings, the company generated positive free cash flow of $115.17M, which indicates a degree of financial flexibility allowing for operational continuity despite accounting losses. The gross margin stands at 67.3%, demonstrating high efficiency in production and supply chain management relative to sales, while the operating margin is -22.5% and the profit margin is -84.4%, signaling that overhead costs and non-operating expenses are eroding profitability. On the balance sheet, the company holds $30.38M in cash against $149.01M in debt, resulting in a debt-to-equity ratio of 29.80. This leverage position suggests the balance sheet is heavily reliant on debt financing, although the positive cash flow provides a buffer against interest obligations. Liquidity is supported by a current ratio of 1.70, which indicates that the company possesses sufficient current assets to cover its short-term liabilities with a comfortable margin. Furthermore, the return on equity is -40.3% and the return on assets is -4.7%, metrics that reveal management is currently unable to generate positive returns on the capital invested in the business.

मूल्यांकन आकलन

Trailing P/E, forward P/E, and price-to-sales ratios are listed as N/A, which implies that traditional earnings-based valuation models are not applicable due to the lack of positive earnings data. The price-to-book ratio is recorded at 0.01, indicating that the market values the company at a fraction of its book value, reflecting a significant discount relative to its net asset worth. Since the price-to-sales and EV/EBITDA metrics are also N/A, the valuation is effectively driven by the market cap and asset book value rather than cash flow generation multiples. The stock has exhibited significant volatility over the past year, trading between a 52-week high of $0.12 and a 52-week low of $0.02. Without a specific current share price provided in the facts, the trading range suggests the asset is priced well below its recent historical high, reflecting investor caution regarding the financial performance. The beta value is -0.07, a highly unusual metric that suggests an inverse relationship to market movements or a calculation anomaly, as stocks typically exhibit positive beta values relative to the broader market.

Growth & Income

Revenue growth year-over-year stands at -1.7%, while earnings growth is N/A due to the negative net income position. The decline in revenue suggests a contraction in the business's top line, and since earnings are negative, there is no earnings growth to compare against the revenue trajectory. The company does not pay dividends, as indicated by the N/A dividend yield and payout ratio, which means the firm retains its cash flow rather than distributing it to shareholders. Consequently, the $115.17M in free cash flow is likely being reinvested into operations or used to service the existing debt obligations rather than being paid out. The overall growth and income profile is characterized by negative revenue expansion, negative profitability, and a lack of dividend income, presenting a challenging outlook for income-focused investors while potentially offering speculative exposure to turnaround potential.